Opaxio (Ovarian Cancer) Analysis and Forecasts to 2020


#28296

26pages

GlobalData

$ 2000

In Stock

 

GlobalDatas pharmaceuticals report, Opaxio (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Opaxio sales forecasts for the US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

 

Scope

 

  • Therapy area profile including patient population for the US
  • Analysis and review of Opaxio including sales data 
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Opaxio including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Detailed sales forecasts for 2014-2020 for Opaxio in the US

 

Reasons to buy

 

  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance 
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

Table of Contents

 

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3


2 Introduction 4
2.1 Ovarian Cancer 4
2.2 Ovarian Cancer Market 4
2.3 Epidemiology 4
2.4 Etiology 6
2.4.1 Age 6
2.4.2 Inherited Gene Mutations 6
2.4.3 A Previous Cancer Diagnosis 6
2.4.4 Early Menstruation or Late menopause 7
2.4.5 Family History of Ovarian Cancer 7
2.5 GlobalData Report Guidance 8


3 Ovarian Cancer: Market Characterization 9
3.1 Ovarian Cancer Market 9
3.2 Ovarian Cancer Market Forecasts and CAGR 9
3.3 Drivers for Ovarian Cancer Market 10
3.3.1 High Incidence 10
3.3.2 High Mortality Rate 11
3.3.3 Increased Use of Chemotherapy in Ovarian Cancer 12
3.3.4 Emergence of Targeted Drugs 12
3.3.5 Recurrence of Tumor 12
3.3.6 Low Initial Diagnosis Rate 12


4 Tumor-Node-Metastases (TNM) Classification of Ovarian Cancer 13


5 Opaxio 16
5.1 Introduction 16
5.2 Mechanism of Action 16
5.3 Clinical Studies 16
5.4 Factors Affecting Sales of Opaxio 17
5.4.1 Unmet Need for Maintenance Therapy 17
5.4.2 Improved Version of Paclitaxel 17
5.4.3 No Clinical Trials conducted in Europe and Japan 17
5.5 Drug Evaluation 18
5.5.1 Drug Risk Benefit Score 18
5.5.2 Intensity of Competition 18
5.6 Sales Forecast 19
5.6.1 Target Patient Pool of Opaxio 19
5.6.2 Dosing 19
5.6.3 Market Penetration 20
5.6.4 Annual Cost of Therapy 20
5.6.5 Sales Projections of Opaxio 21


6 Ovarian Cancer Market: Appendix 22
6.1 Market Definitions 22
6.2 List of Abberiviations 22
6.3 Research Methodology 23
6.3.1 Coverage 23
6.3.2 Secondary Research 23
6.3.3 Forecasting 23
6.3.4 Number of Patients Approved to take the Drug 24
6.3.5 Net Penetration of Drug 25
6.3.6 Net Annual Dosing 25
6.3.7 Annual Cost of Therapy 25
6.3.8 Primary Research 25
6.3.9 Expert Panels 26
6.4 Contact Us 26
6.5 Disclaimer 26
6.6 Sources 26


Table 1: Ovarian Cancer, Incidences and Mortality, 20082030 6
Table 2: Ovarian Cancer, Global, Market Size Forecasts ($m), 20092020 9
Table 3: Detailed TNM Classification 14
Table 4: Drug Risk Benefit Score 18
Table 5: Opaxio, Ovarian Cancer, Global, Sales Forecasts ($m), 20142020 21


Figure 1: Distribution by Incidence and Mortality, Most Frequently Diagnosed Cancers, Worldwide, 2010 5
Figure 2: Ovarian Cancer, Global, Market Size Forecasts ($m), 20092020 9
Figure 3: Ovarian Cancer, Worldwide, Incidence (in million), 2008-2030 10
Figure 4: Oncology, Worldwide, Incidence (in million), 2008-2030 11
Figure 5: Ovarian Cancer, Worldwide, Mortality (in million), 2008-2030 11
Figure 6: Broad Classification of Ovarian Cancer 13
Figure 7: Classification of Ovarian Cancer 15
Figure 8: Drug Model Diagram of Opaxio 19
Figure 9: Opaxio, Ovarian Cancer, Global, Sales Forecasts ($m), 20142020 21
Figure 10: Drug Model Diagram 24
Figure 11: Patients Approved for the Drug 24